Medical School

  • New York University , 2011 , New York , NY


  • Boston Children's Hospital/Boston Medical Center , 2012 , Boston , MA


  • Boston Children's Hospital/Boston Medical Center , 2014 , Boston , MA


Region 1 New England Pediatric Environmental Health Specialty Unit
  • Boston Children's Hospital , 2015 , Boston , MA


Marissa Hauptman, MD, MPH is a board certified pediatrician and a pediatric environmental health specialist at the Region 1 New England Pediatric Environmental Health Specialty Unit in the Division of General Pediatrics at Boston Children’s Hospital. She earned both a Bachelor of Science degree in Applied Mathematics/Biology and a Master of Public Health (MPH) degree in Social and Environmental Epidemiology at Brown University in Providence, Rhode Island. She earned her Medical Degree at New York University School of Medicine.  She completed her pediatrics residency in the Urban Health and Advocacy Track at the Boston Combined Residency Program in Pediatrics at Boston Children’s Hospital and Boston Medical Center. 

Dr. Hauptman’s research focuses on using spatial analysis techniques to research and improve environmental and social health disparities in urban children. Dr. Hauptman is currently engaged in a research project evaluating the impact of spatial and environmental exposures on asthma morbidity as part of the NIH funded School- Inner City Asthma Study, led by principal investigator, Dr. Wanda Phipatanakul.  She has been awarded the 2015 Academic Pediatric Association Research Award for Best Abstract by a Fellow for her research abstract entitled “Residential and School Proximity To Major Roadways and Asthma Morbidity in the School Inner-City Asthma Study” that was presented at the Pediatric Academic Societies (PAS) Annual Meeting in 2015.She has also been awarded the American Academy of Pediatrics Section on Allergy and Immunology Outstanding Abstract Award at the 2016 American Academy of Allergy, Asthma and Immunology Annual Meeting, which recognized significant research efforts in the field of asthma, allergy or immunology in children.

Dr. Hauptman has served on the Medical Review Panel for Lead Poisoning for the Massachusetts Department of Health, Bureau of Environmental Health in partnership with the Pediatric Environmental Health Center at Boston Children’s Hospital. Dr. Hauptman has also served as a commissioner on the Rhode Island Attorney General’s Advisory Commission on Lead Paint from 2005 to 2007. She was awarded a 2007 Rhode Island Healthy Housing Award by the Childhood Lead Poisoning Prevention Program of the Rhode Island Department of Health for her efforts in the development of strategies that promote healthy environments for children and families in the State of Rhode Island. 


  • American Board of Pediatrics, General Pediatrics


Publications powered by Harvard Catalyst Profiles

  1. Isolation and characterization of extracellular vesicles in saliva of children with asthma. Extracell Vesicles Circ Nucl Acids. 2021; 2:29-48. View abstract
  2. Understanding Rising Electronic Cigarette Use. Obstet Gynecol. 2021 03 01; 137(3):521-527. View abstract
  3. The COVID-19 Pandemic and Children's Environmental Health. Pediatr Ann. 2020 Dec 01; 49(12):e537-e542. View abstract
  4. Asthma Prevalence and Mold Levels in US Northeastern Schools. J Allergy Clin Immunol Pract. 2021 03; 9(3):1312-1318. View abstract
  5. Lead exposure and association with angiogenic factors and hypertensive disorders of pregnancy. Pregnancy Hypertens. 2020 Oct; 22:93-98. View abstract
  6. Differential Effect of School-Based Pollution Exposure in Children With Asthma Born Prematurely. Chest. 2020 10; 158(4):1361-1363. View abstract
  7. The hazards of wildfire smoke exposure for children. Curr Probl Pediatr Adolesc Health Care. 2020 02; 50(2):100756. View abstract
  8. Severe lead poisoning requiring hospitalization: A case report. Curr Probl Pediatr Adolesc Health Care. 2020 02; 50(2):100757. View abstract
  9. Doc, can you test me for "toxic metals"? Challenges of testing for toxicants in patients with environmental concerns. Curr Probl Pediatr Adolesc Health Care. 2020 02; 50(2):100762. View abstract
  10. The Legacy of Environmental Policies-Are We Doing Enough? JAMA Pediatr. 2020 02 01; 174(2):126-128. View abstract
  11. Climate changes reproductive and children's health: a review of risks, exposures, and impacts. Pediatr Res. 2020 01; 87(2):414-419. View abstract
  12. Proximity to major roadways and asthma symptoms in the School Inner-City Asthma Study. J Allergy Clin Immunol. 2020 01; 145(1):119-126.e4. View abstract
  13. Toward the elimination of bias in Pediatric Research. Pediatr Res. 2019 12; 86(6):680-681. View abstract
  14. Classroom indoor PM2.5 sources and exposures in inner-city schools. Environ Int. 2019 10; 131:104968. View abstract
  15. Children With Autism Spectrum Disorder and Lead Poisoning: Diagnostic Challenges and Management Complexities. Clin Pediatr (Phila). 2019 06; 58(6):605-612. View abstract
  16. Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies. Mol Genet Metab. 2018 06; 124(2):161-167. View abstract
  17. Environmental Control: The First Tenet of Allergy. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):36-37. View abstract
  18. Childhood Ingestions of Environmental Toxins: What Are the Risks? Pediatr Ann. 2017 Dec 01; 46(12):e466-e471. View abstract
  19. Nitrogen dioxide exposure in school classrooms of inner-city children with asthma. J Allergy Clin Immunol. 2018 06; 141(6):2249-2255.e2. View abstract
  20. Lead Poisoning and Children in Foster Care: Diagnosis and Management Challenges. Clin Pediatr (Phila). 2018 07; 57(8):988-991. View abstract
  21. An Update on Childhood Lead Poisoning. Clin Pediatr Emerg Med. 2017 Sep; 18(3):181-192. View abstract
  22. Adherence and stress in a population of inner-city children with asthma. Pediatr Allergy Immunol. 2017 09; 28(6):610-612. View abstract
  23. Impact of school peanut-free policies on epinephrine administration. J Allergy Clin Immunol. 2017 Aug; 140(2):465-473. View abstract
  24. In Reply. Obstet Gynecol. 2016 12; 128(6):1447. View abstract
  25. Comparison of treatment modalities for inpatient asthma exacerbations among US pediatric hospitals. J Allergy Clin Immunol Pract. 2017 May - Jun; 5(3):855-857.e1. View abstract
  26. Insect Repellants During Pregnancy in the Era of the Zika Virus. Obstet Gynecol. 2016 11; 128(5):1111-1115. View abstract
  27. Modeling indoor particulate exposures in inner-city school classrooms. J Expo Sci Environ Epidemiol. 2017 09; 27(5):451-457. View abstract
  28. Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children. J Allergy Clin Immunol. 2016 11; 138(5):1467-1471.e9. View abstract
  29. Recent advances in environmental controls outside the home setting. Curr Opin Allergy Clin Immunol. 2016 Apr; 16(2):135-41. View abstract
  30. The school environment and asthma in childhood. Asthma Res Pract. 2015; 1. View abstract
  31. Year in review: pediatric allergy and asthma, excluding food allergy. Ann Allergy Asthma Immunol. 2015 Mar; 114(3):175-7. View abstract
  32. Index of suspicion. Pediatr Rev. 2014 Sep; 35(9):396-404. View abstract
  33. The important health impact of where a child lives: neighborhood characteristics and the burden of lead poisoning. Matern Child Health J. 2011 Nov; 15(8):1195-202. View abstract
  34. State of Lead in Rhode Island: Using GIS Analysis in the Development of a Lead Poisoning Prevention Program. 2007. View abstract